Laddar...
Drugs for rare diseases
Pharmaceutical houses alone are equipped to market new medicines. The cost is very high, much of this arising from the preliminary toxicological and pharmacological work which is required in order to satisfy licensing authorities. The introduction of a drug, even for a rare and lethal disease withou...
Sparad:
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
1974
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2495483/ https://ncbi.nlm.nih.gov/pubmed/4465769 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|